Endpoints News ٩ أبريل ٢٠٢٦ Roche dips into DACs with existing partner C4 Therapeutics for $20M upfront
Endpoints News ٢١ مارس ٢٠٢٦ Roche, Nvidia’s 'AI Factory'; Industry looks to soften MFN impact; Structure’s oral GLP-1 data; and more
Endpoints News ١٤ مارس ٢٠٢٦ Roche’s breast cancer failure; BioNTech co-founders to depart; Eli Lilly’s quest to stay on top; and more
Endpoints News ٢ مارس ٢٠٢٦ Roche gets third pivotal win with MS drug, but liver signal could be a problem
Endpoints News ٩ فبراير ٢٠٢٦ #ACTRIMS26: Roche’s MS drug fenebrutinib beats Ocrevus, cutting risk of disability progression by 12%
Endpoints News ٨ يناير ٢٠٢٦ Ollin’s drug clears retinal disease better than Roche’s Vabysmo in Phase 1b trial
Endpoints News ٨ يناير ٢٠٢٦ Charles Fuchs leaves Roche to steer ADC pipeline at Tubulis shortly after $401M Series C